Our affiliates that we refer to above may include, among others, UBS Securities LLC, UBS Financial Services Inc. and Credit Suisse Securities (USA) LLC.
Branches
We expect to issue the securities acting through, and to book the securities through our Jersey branch, our London branch, or such other branch as is specified in the applicable prospectus supplement.
Conflicts of Interest
Each of UBS Securities LLC, UBS Financial Services Inc. and Credit Suisse Securities (USA) LLC is an affiliate of UBS AG and, as such, has a “conflict of interest” in any offering of the securities within the meaning of FINRA Rule 5121. If UBS Securities LLC, UBS Financial Services Inc., Credit Suisse Securities (USA) LLC or any of our other U.S.-registered broker-dealer subsidiaries or affiliates participate in the distribution of the securities, we will conduct the offering in accordance with the applicable provisions of FINRA Rule 5121. None of UBS Securities LLC, UBS Financial Services Inc. or Credit Suisse Securities (USA) LLC will be permitted to sell securities in any offering to an account over which it exercises discretionary authority without the prior specific written approval of the account holder.
Risk Factors Relating to UBS AG and Other Considerations Relating to the Securities
The securities are not bank deposits: An investment in the securities carries risks which are very different from the risk profile of a bank deposit placed with UBS AG, UBS Switzerland AG or its affiliates. The securities have different yield and/or return, liquidity and risk profiles and would not benefit from any protection provided to deposits.
For a discussion of important business and financial risks relating to UBS AG, please see “Risk Factors” in Part I, Item 3D of the UBS AG 2023 20-F, which is incorporated in this prospectus by reference (and in any of our annual or quarterly reports for a subsequent fiscal period that are so incorporated).
There are a number of considerations that you should take into account prior to investing in the securities. Please read “Considerations Relating to Indexed Securities,” “Considerations Relating to Floating Rate Debt Securities” and “Considerations Relating to Securities Denominated or Payable in or Linked to a Non-U.S. Dollar Currency” for more information.
Cautionary Note Regarding Forward-Looking Statements
This prospectus, any prospectus supplement and the documents incorporated by reference contain statements that constitute “forward-looking statements,” as that term is defined in Section 27A of the Securities Act of 1933 (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934 (the “Exchange Act”), as amended by the Private Securities Litigation Reform Act of 1995, including but not limited to management’s outlook for UBS’s financial performance, statements relating to the anticipated effect of transactions and strategic initiatives on UBS’s business and future development and goals or intentions to achieve climate, sustainability and other social objectives. Forward-looking statements can sometimes be identified by the use of forward-looking terms such as “believes,” “expects,” “may,” “will,” “shall,” “should,” “would,” “could,” “potential,” “seeks,” “aims,” “projects,” “predicts,” “is optimistic,” “intends,” “plans,” “estimates,” “targets,” “anticipates,” “continues” or other comparable terms or negatives of these terms, but not all forward-looking statements include such identifying words.
While these forward-looking statements represent UBS’s judgments, expectations and objectives concerning the matters described, a number of risks, uncertainties and other important factors could cause actual developments and results to differ materially from UBS’s expectations. In particular, the global economy may be
3